Clinical Profile and Outcome of Patients with Rheumatoid Arthritis Associated Interstitial Lung Disease in Addis Ababa: A Multicentric, Five Year Retrospective Study
No Thumbnail Available
Date
2025-04-15
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Addis Ababa University
Abstract
Background: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a severe complication of rheumatoid arthritis, leading to significant morbidity and mortality. However, there is limited data on its clinical characteristics, serology, imaging, health-related quality of life, and predictors of poor treatment outcomes in resource-limited settings, including Ethiopia.
Objective: This study aims to evaluate the clinical profile, imaging characteristics, laboratory findings, and factors associated with poor treatment outcomes among patients with RA-ILD in selected specialized hospitals in Addis Ababa.
Methods: This is a multicenter retrospective cohort study utilizing electronic medical records (EMRs) and phone call interviews from RA patients diagnosed with RA-ILD between February 2020 and February 2025. Data on demographics, clinical presentations, radiological findings (HRCT), PFT results, and serological markers were collected using a structured data collection tool. Descriptive statistics was used to calculate the frequency and percentage of both dependent and independent variables. Logistic regression was employed to explore the relationship between the outcome variable and the independent variables.
Results: A total of 62 patients were included in the study, with the majority being female (95.2%) and a mean age of 53.3 ± 12.6 years. The most common symptoms were cough (93.5%), fatigue (43.5%), and dyspnea (35.5%). Serological testing revealed high positivity for rheumatoid factor (83.9%) and anti-cyclic citrullinated peptide (anti-CCP) antibodies (88.7%). HRCT findings indicated that all patients had reticulation, and 90.3% had traction bronchiectasis. A usual Interstitial Pneumonia (UIP) pattern was present in 68% of cases. All patients were diagnosed with restrictive pulmonary disease. The overall poor treatment outcome rate was 61.3%, with a mortality rate of 11.3%. No significant associations between clinical, laboratory, or imaging variables and poor outcomes were identified, likely due to the study's small sample size. However, RF positivity, fatigability, higher subjective pain score, longer ILD treatment duration, and high DAS-28 ESR showed trends toward potential association with poor outcome, while methotrexate use showed a trend toward reduction in the odds of poor treatment outcomes.
Conclusion: This study is the first to evaluate RA-ILD in Ethiopia, revealing a high prevalence of respiratory symptoms, positive serological markers, and characteristic HRCT patterns. Despite this, the high rate of poor treatment outcomes and mortality emphasizes the need for early detection and management. Larger studies are needed to further investigate these findings and refine treatment strategies for RA-ILD in Ethiopia.
Keywords: RA; RA-ILD; Risk factors; Ethiopia
Description
Keywords
RA RA-ILD Risk factors Ethiopia